SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-19-025561
Filing Date
2019-12-06
Accepted
2019-12-06 17:25:42
Documents
12
Period of Report
2019-12-05
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k120519_nektartherape.htm   iXBRL 8-K 21757
  Complete submission text file 0001213900-19-025561.txt   193306

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE nktrcom-20191205.xsd EX-101.SCH 3173
3 XBRL LABEL FILE nktrcom-20191205_lab.xml EX-101.LAB 34581
4 XBRL PRESENTATION FILE nktrcom-20191205_pre.xml EX-101.PRE 22695
8 EXTRACTED XBRL INSTANCE DOCUMENT f8k120519_nektartherape_htm.xml XML 3500
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

IRS No.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-24006 | Film No.: 191273881
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences